近些年的临床研究发现血管紧张素转换酶抑制剂(ACEI)和血管紧张素Ⅱ受体阻滞剂(ARBs)具有独特的肾脏保护作用,这个观点已经越来越多地被接受。因此各个国家以及各个专业委员会的指南也特别强调这类药物应该用于治疗那些患有肾脏病的高血压患者,暗示这类药物有独立于降压作用之 In recent years, clinical studies have found that angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) have a unique renal protective effect, a view that has been increasingly accepted. Therefore, the guidelines of various countries and professional committees also emphasize that such drugs should be used to treat those hypertensive patients with kidney disease, suggesting that these drugs have antihypertensive effect